0001517420-16-000002.txt : 20160603 0001517420-16-000002.hdr.sgml : 20160603 20160603165336 ACCESSION NUMBER: 0001517420-16-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160603 DATE AS OF CHANGE: 20160603 EFFECTIVENESS DATE: 20160603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AnaBios Corp CENTRAL INDEX KEY: 0001517420 IRS NUMBER: 270755353 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-264190 FILM NUMBER: 161696397 BUSINESS ADDRESS: STREET 1: 3030 BUNKER HILL STREET CITY: SAN DIEGO STATE: X1 ZIP: 92109 BUSINESS PHONE: 203-245-0280 MAIL ADDRESS: STREET 1: 3030 BUNKER HILL STREET CITY: SAN DIEGO STATE: X1 ZIP: 92109 D/A 1 primary_doc.xml X0707 D/A LIVE 0001517420 AnaBios Corp 3030 BUNKER HILL STREET SAN DIEGO X1 UNITED STATES 92109 203-245-0280 DELAWARE AnaBioCardia Corporation None Corporation true Andre Ghetti c/o AnaBios Corp 3030 Bunker Hill Street, Suite 312 San Diego CA CALIFORNIA 92109 Executive Officer Paul Miller c/o AnaBios Corp 3030 Bunker Hill Street, Suite 312 San Diego CA CALIFORNIA 92109 Executive Officer Martin J. Waters c/o AnaBios Corp 3030 Bunker Hill Street, Suite 312 San Diego CA CALIFORNIA 92109 Executive Officer Jack Reynolds c/o AnaBios Corp 3030 Bunker Hill Street, Suite 312 San Diego CA CALIFORNIA 92109 Executive Officer Director Richard F. Erdman c/o AnaBios Corp 3030 Bunker Hill Street, Suite 312 San Diego CA CALIFORNIA 92109 Director Biotechnology Decline to Disclose 06b true 0001517420-16-000001 2016-05-18 false true false 0 CIM Securities, LLC None CIM Securities, LLC 120852 6898 S. University Blvd. Centennial CO COLORADO 80122 CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA HI HAWAII IL ILLINOIS MI MICHIGAN NJ NEW JERSEY NY NEW YORK SC SOUTH CAROLINA TX TEXAS WI WISCONSIN WY WYOMING false Brookline Group, LLC None Brookline Group, LLC 153587 2501 20th Place South Birmingham AL ALABAMA 35223 AL ALABAMA false 8385556 5128808 3256748 $613,251.37 in conversion of promissory notes to Series B Preferred Stock (principal & interest); $3,630,000.00 in new money; $885,556.71 in conversion of promissory notes to Series A Preferred Stock (principal & interest) false 62 0 254100 0 false AnaBios Corp /Andre Ghetti/ Andre Ghetti President & CEO 2016-06-03